These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients. Singh MM, Kumar R, Tewari S, Agarwal S. Ann Hum Genet; 2017 May; 81(3):117-124. PubMed ID: 28244588 [Abstract] [Full Text] [Related]
44. Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Dong SS, Liu XG, Chen Y, Guo Y, Wang L, Zhao J, Xiong DH, Xu XH, Recker RR, Deng HW. Calcif Tissue Int; 2009 Aug; 85(2):104-12. PubMed ID: 19458885 [Abstract] [Full Text] [Related]
47. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. Knevel R, de Rooy DP, Saxne T, Lindqvist E, Leijsma MK, Daha NA, Koeleman BP, Tsonaka R, Houwing-Duistermaat JJ, Schonkeren JJ, Toes RE, Huizinga TW, Brouwer E, Wilson AG, van der Helm-van Mil AH. Arthritis Res Ther; 2014 May 07; 16(3):R108. PubMed ID: 24886600 [Abstract] [Full Text] [Related]
48. The relationship between chemerin, bone metabolism, the RANKL/RANK/OPG system, and bone mineral density in girls with anorexia nervosa. Ostrowska Z, Morawiecka-Pietrzak M, Pluskiewicz W, Świętochowska E, Strzelczyk J, Gołąbek K, Gaździcka J, Ziora K. Endokrynol Pol; 2022 May 07; 73(1):26-34. PubMed ID: 35119086 [Abstract] [Full Text] [Related]
49. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Choi JY, Shin A, Park SK, Chung HW, Cho SI, Shin CS, Kim H, Lee KM, Lee KH, Kang C, Cho DY, Kang D. Calcif Tissue Int; 2005 Sep 07; 77(3):152-9. PubMed ID: 16151677 [Abstract] [Full Text] [Related]
50. Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS). Boonen S, Pye SR, O'Neill TW, Szulc P, Gielen E, Borghs H, Verschueren S, Claessens F, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Tajar A, Wu FC, Vanderschueren D, EMAS Group. Eur J Endocrinol; 2011 Dec 07; 165(6):977-86. PubMed ID: 21903895 [Abstract] [Full Text] [Related]
51. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvien TK, Lems WF. Ann Rheum Dis; 2006 Nov 07; 65(11):1495-9. PubMed ID: 16606653 [Abstract] [Full Text] [Related]
52. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. Rouster-Stevens KA, Langman CB, Price HE, Seshadri R, Shore RM, Abbott K, Pachman LM. Arthritis Rheum; 2007 Mar 07; 56(3):977-83. PubMed ID: 17328075 [Abstract] [Full Text] [Related]
56. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. Yin LL, Jing N, Zhao ZY, Liu XH, Du J, Qin LL, Song JG, Xu Y. Eur Rev Med Pharmacol Sci; 2017 Jan 07; 21(1):37-41. PubMed ID: 28121359 [Abstract] [Full Text] [Related]
57. Genetic polymorphism of the OPG gene associated with breast cancer. Ney JT, Juhasz-Boess I, Gruenhage F, Graeber S, Bohle RM, Pfreundschuh M, Solomayer EF, Assmann G. BMC Cancer; 2013 Jan 31; 13():40. PubMed ID: 23369128 [Abstract] [Full Text] [Related]
59. The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis. Yang H, Liu W, Zhou X, Rui H, Zhang H, Liu R. Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31209146 [Abstract] [Full Text] [Related]